Table 3.
Pathogen | Antifungal agent | MIC50 (μg/mL) | MIC90 (μg/mL) |
---|---|---|---|
Aspergillus fumigatus | Isavuconazole | 0.25–1 | 0.5–2 |
Voriconazole | 0.25–1 | 0.5–2 | |
Caspofungin | 0.06–0.5 | 0.06–0.5 | |
Amphotericin B | 0.25–4 | 0.5–8 | |
Aspergillus terreus | Isavuconazole | 0.5–1 | 0.5–4 |
Voriconazole | 0.25–1 | 0.5–2 | |
Caspofungin | 0.03–0.5 | 0.06–0.5 | |
Amphotericin B | 1–4 | 1–8 | |
Aspergillus flavus | Isavuconazole | 0.5–2 | 1–16 |
Voriconazole | 0.5–1 | 0.5–2 | |
Caspofungin | 0.03–0.25 | 0.03–0.25 | |
Amphotericin B | 1–2 | 1–4 | |
Aspergillus niger | Isavuconazole | 0.5–2 | 2–4 |
Voriconazole | 0.25–2 | 1–2 | |
Caspofungin | 0.06–0.25 | 0.125–0.25 | |
Amphotericin B | 0.5–1 | 0.5–2 |
Note: Copyright © 2010, Springer Science and Business Media. Adapted with permission from Thompson GR III, Wiederhold NP. Isavuconazole: a comprehensive review of spectrum of activity of a new triazole. Mycopathologia. 2010;170(5):291–313.18
Abbreviation: MIC, minimum inhibitory concentration.